BRIEF-Fireswirl reports fourth quarter results
* Fireswirl announces audited fourth quarter and fiscal year 2016 financial results
Jan 3 Inotek Pharmaceuticals Corp said on Tuesday that its treatment for glaucoma did not meet its main goal in the first pivotal late-stage study.
The company said the main goal of superiority was not achieved over a placebo.
(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel)